Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.
Study identifies α-MSH as therapeutic candidate for corneal endothelial disease
- Post author:
- Post published:January 2, 2024
- Post category:uncategorized